Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Lymphoid 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Lung Neoplasms 5Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Smoking 1Skin Neoplasms 1Prostatic Neoplasms 1Neoplasms 1Lymphoma, Non-Hodgkin 1Lung Cancer Screening 1Endometrial Neoplasms 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

pembrolizumab 30Carboplatin 13Trastuzumab 8Paclitaxel 7Nivolumab 7Cisplatin 6Ipilimumab 5Cetuximab 5Bevacizumab 5Taxes 4Pemetrexed 4Specimen Handling 3Irinotecan 3Docetaxel 3Cyclophosphamide 3Biopsy 3tisotumab vedotin 2temsirolimus 2spartalizumab 2sargramostim 2pertuzumab 2lenvatinib 2fludarabine 2epacadostat 2enzalutamide 2aldesleukin 2X-Rays 2Ritonavir 2Psychiatric Rehabilitation 2Oxaliplatin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrial Neoplasms × Mass Screening × Thoracic × Clear all
NCT00859768 2011-03-08

The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients

Netherlands Open University

Phase NA Completed
568 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicLymphoidThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Lung Neoplasms, Lymphoma, Non-Hodgkin, Neoplasms, Prostatic Neoplasms, Skin Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡